Blood and Circulatory System Disorders



Blood and Circulatory System Disorders


Learning Objectives


After studying this chapter, the student is expected to:



Key Terms


achlorhydria


agglutination


autoregulation


bilirubin


cyanotic


demyelination


deoxyhemoglobin


diapedesis


dyscrasia


dyspnea


ecchymoses


erythrocytosis


erythropoietin


ferritin


gastrectomy


glossitis


hemarthrosis


hematocrit


hematopoiesis


hemolysis


hemoptysis


hemosiderin


hemostasis


hepatomegaly


hypochromic


interleukin


leukocytosis


leukopenia


leukopoiesis


macrocytes


macrophages


malabsorption


megaloblasts


microcytic


morphology


myelotoxins


myelodysplastic


neutropenia


oxyhemoglobin


pallor


pancytopenia


petechiae


phlebotomy


plasma


plethoric


reticulocyte


serum


splenomegaly


stomatitis


syncope


tachycardia


thrombocytopenia


Review of the Circulatory System and Blood


Anatomy, Structures, and Components


As any student of anatomy and physiology quickly discovers, although distinct in their specific structures and functions, all the systems of the human body are intricately interrelated and must interact constantly in order to maintain the proper functioning of the body. One component upon which all systems depend is blood that: transports essential oxygen to all tissues along with nutrients required for cellular metabolism, provides for the necessary removal of many cell wastes, plays a critical role in the body’s defenses/immune system and serves in maintaining body homeostasis. Blood and lymph, another essential body fluid, are transported throughout the body via a complex system of vessels and the pumping action of the heart. Due to the complexity and distinct features involved in the production and circulation of blood and lymph, this chapter examines blood itself along with a basic review of the vessels involved in the distribution of blood throughout the body and the associated blood disorders. Chapter 11 presents an examination of the lymphatic system and associated disorders. Chapter 12 presents a detailed examination of the cardiovascular system with specific emphasis on the heart and associated disorders along with disorders of the blood vessels themselves.


Blood Vessels


The arteries, capillaries, and veins constitute a closed system for the distribution of blood throughout the body. Major blood vessels, most of which are paired left and right, are shown in Figures 10-1 and 10-2.




To review the components of the circulatory system:



• There are two separate circulations—the pulmonary circulation allows the exchange of oxygen and carbon dioxide in the lungs, and the systemic circulation provides for the exchange of nutrients and wastes between the blood and the cells throughout the body.


• Arteries transport blood away from the heart into the lungs or to body tissues.


• Arterioles are the smaller branches of arteries that control the amount of blood flowing into the capillaries in specific areas through the degree of contraction of smooth muscle in the vessel walls (vasoconstriction or dilation).


• Capillaries are very small vessels organized in numerous networks that form the microcirculation. Blood flows very slowly through capillaries, and precapillary sphincters determine the amount of blood flowing from the arterioles into the individual capillaries, depending on the metabolic needs of the tissues.


• Small venules conduct blood from the capillary beds toward the heart.


• Larger veins collect blood draining from the venules. Normally a high percentage of the blood (approximately 70%) is located in the veins at any one time; hence, the veins are called capacitance vessels. Blood flow in the veins depends on skeletal muscle action, respiratory movements, and gravity. Valves in the larger veins in the arms and legs have an important role in keeping the blood flowing toward the heart. Respiratory movements assist the movement of blood through the trunk.


The walls of arteries and veins are made up of three layers.



The vasa vasorum consists of tiny blood vessels that supply blood to the tissues of the wall itself. Normally the large arteries are highly elastic in order to adjust to the changes in blood volume that occur during the cardiac cycle. For example, the aorta must expand during systole to prevent systolic pressure from rising too high, and during diastole the walls must recoil to maintain adequate diastolic pressure. Veins have thinner walls than arteries and less smooth muscle (Fig. 10-3).



Localized vasodilation or vasoconstriction in arterioles is controlled by autoregulation, a reflex adjustment in a small area of a tissue or an organ, which varies depending on the needs of the cells in the area. For example, a decrease in pH, an increase in carbon dioxide, or a decrease in oxygen leads to local vasodilation. Release of chemical mediators such as histamine or an increase in temperature at a specific area can also cause vasodilation. These local changes do not affect the systemic blood pressure.


Norepinephrine and epinephrine increase systemic vasoconstriction by stimulating alpha1-adrenergic receptors in the arteriolar walls. Angiotensin is another powerful systemic vasoconstrictor. At all times, even at rest, vascular or vasomotor tone is maintained by constant input from the SNS that results in partial vasoconstriction throughout the body to ensure continued circulation of blood.


Capillary walls consist of a single endothelial layer to facilitate the exchange of fluid, oxygen, carbon dioxide, electrolytes, glucose and other nutrients, and wastes between the blood and the interstitial fluid. Capillary exchange and abnormal electrolyte shifts are discussed in Chapter 2.



Blood


Blood provides the major transport system of the body for essentials such as oxygen, glucose and other nutrients, hormones, electrolytes, and cell wastes. It serves as a critical part of the body’s defenses, carrying antibodies and white blood cells for the rapid removal of any foreign material. As a vehicle promoting homeostasis, blood provides a mechanism for controlling body temperature by distributing core heat throughout the peripheral tissues. Blood is the medium through which body fluid levels and blood pressure are measured and adjusted by various controls, such as hormones. Clotting factors in the circulating blood are readily available for hemostasis. Buffer systems in the blood maintain a stable pH of 7.35 to 7.45 (see discussion of acid-base balance in Chapter 2).


Composition of Blood


The adult body contains approximately 5 liters of blood. Blood consists of water and its dissolved solutes, which make up about 55% of the whole blood volume; the remaining 45% is composed of the cells or formed elements, the erythrocytes, along with leukocytes, and thrombocytes or platelets. Hematocrit refers to the proportion of cells (essentially the erythrocytes) in blood and indicates the viscosity of the blood. Males have a higher hematocrit, average 42% to 52%, than females, 37% to 47%. An elevated hematocrit could indicate dehydration (loss of fluid) or excess red blood cells. A low hematocrit might result from blood loss or anemia. Plasma is the clear yellowish fluid remaining after the cells have been removed, and serum refers to the fluid and solutes remaining after the cells and fibrinogen have been removed. The plasma proteins include albumin, which maintains osmotic pressure in the blood; globulins or antibodies; and fibrinogen, which is essential for the formation of blood clots.


The components of blood and their functions are summarized in Figure 10-4. Normal values for blood components are found inside the front cover of this book.



Blood Cells and Hematopoiesis


All blood cells originate from the red bone marrow. In the adult, red bone marrow is found in the flat and irregular bones, ribs, vertebrae, sternum, and pelvis. The iliac crest in the pelvic bone is a common site for a bone marrow aspiration for biopsy. The various blood cells develop from a single stem cell (pluripotential hematopoietic stem cell) during the process of hemopoiesis or hematopoiesis (Fig. 10-5). From this basic cell, the differentiation process forms committed stem cells for each type of blood cell. These cells then proliferate and mature, providing the specialized functional cells needed by the body. A pathological condition of the blood that usually refers to disorders involving the cellular components of blood is called dyscrasia. A number of specific blood dyscrasias are addressed later in the chapter.



Erythrocytes or red blood cells (RBCs) are biconcave, flexible discs (like doughnuts but with thin centers rather than holes) that are non-nucleated when mature and contain hemoglobin (Fig. 10-6). The size and structure are essential for easy passage through small capillaries. The hormone erythropoietin, originating from the kidney, stimulates erythrocyte production in the red bone marrow in response to tissue hypoxia, or insufficient oxygen available to cells. Normally RBCs (4.2 to 6.2 million/mm3) constitute most of the cell volume in blood. Adequate RBC production and maturation depend on the availability of many raw materials, including amino acids, iron, vitamin B12, vitamin B6, and folic acid.



Hemoglobin consists of the globin portion, two pairs of amino acid chains, and four heme groups, each containing a ferrous iron atom, to which the oxygen molecule (O2) can attach (see Fig. 10-16A). Heme provides the red color associated with hemoglobin. Normally hemoglobin becomes fully saturated with oxygen in the lungs. Oxyhemoglobin is a bright red color, which distinguishes arterial blood from venous blood. As the blood circulates through the body, oxygen dissociates from hemoglobin, depending on local metabolism (see Fig. 13-6). Deoxygenated hemoglobin (deoxyhemoglobin or reduced hemoglobin) is dark or bluish-red in color and is found in venous blood.


Only a small proportion of the carbon dioxide (CO2) in blood is carried by hemoglobin (carbaminohemoglobin) attached to nitrogen in an amino acid group at a different site from that for oxygen. Most carbon dioxide is transported in blood as bicarbonate ion (in the buffer pair). Oxygen can easily be displaced from hemoglobin by carbon monoxide, which binds tightly to the iron, thus causing a fatal hypoxia (deficit of oxygen). Carbon monoxide poisoning can be recognized by the bright cherry-red color in the lips and face.


The lifespan of a normal RBC is approximately 120 days. As it ages, the cell becomes rigid and fragile and finally succumbs to phagocytosis in the spleen or liver and is broken down into globin and heme (Fig. 10-7). Globin is broken down into amino acids, which can be recycled in the amino acid pool, and the iron can be returned to the bone marrow and liver to be reused in the synthesis of more hemoglobin. Excess iron can be stored as ferritin or hemosiderin in the liver, blood, and other body tissues. A genetic disorder, hemochromatosis, otherwise known as iron overload, results in large amounts of hemosiderin accumulating in the liver, heart, and other organs, causing serious organ damage.



The balance of the heme component is converted to bilirubin and transported by the blood to the liver, where it is conjugated (or combined) with glucuronide to make it more soluble, and then excreted in the bile. Excessive hemolysis or destruction of RBCs may cause elevated serum bilirubin levels, which result in jaundice, the yellow color in the sclera of the eye and of the skin.


Hematopoiesis

Leukocytes, which number 5 to 10,000/mm3, make up only about 1% of blood volume. They are subdivided into three types of granulocytes and two types of agranulocytes. All types develop and differentiate from the original stem cell in bone marrow (see Fig. 10-5). Leukopoiesis, or production of white blood cells (WBCs), is stimulated by colony-stimulating factors (CSFs) produced by cells such as macrophages and T lymphocytes. For example, granulocyte CSF or multi-CSF (interleukin-3 [IL-3]) may be produced to increase certain types of WBCs during an inflammatory response (see Chapter 5). White blood cells may leave the capillaries and enter the tissues by diapedesis or ameboid action (movement through an intact capillary wall) when they are needed for defensive purposes.


The five types of leukocytes vary in physical characteristics and functions (see Fig. 10-4). Some examples of WBCs are visible as large, nucleated cells (purple stain) in the blood smear in Figure 10-8.



• Lymphocytes make up 30% to 40% of the WBCs. The roles of B and T lymphocytes in the immune response are reviewed in Chapter 7. Some T cells are designated natural killer cells and are significant in immunity.


• Neutrophils (also called polys, segs, or PMNs) are the most common leukocyte, comprising 50% to 60% of WBCs, but they survive only 4 days. They are the first to respond to any tissue damage and commence phagocytosis. An immature neutrophil is called a band or stab, and these are increased in numbers by bacterial infection. The laboratory reports note this as a “shift to the left” in the pattern of leucocytes seen.


• Basophils appear to migrate from the blood and enter tissue to become mast cells that can release histamine and heparin. They may be fixed in tissues or wandering.


• Eosinophils tend to combat the effects of histamine. They are increased by allergic reactions and parasitic infections.


• Monocytes can enter the tissue to become macrophages, which act as phagocytes when tissue damage occurs.


A differential count indicates the proportions of specific types of WBCs in the blood and frequently assists in making a diagnosis. For example, a bacterial infection or inflammatory condition stimulates an increase in neutrophils, whereas allergic reactions or parasitic infections increase the eosinophil count.



Thrombocytes, also called platelets, are an essential part of the blood-clotting process or hemostasis (Fig. 10-9). Thrombocytes are not cells; rather, they are very small, irregularly shaped, non-nucleated fragments from large megakaryocytes (see Fig. 10-8). Platelets stick to damaged tissue as well as to each other to form a platelet plug that seals small breaks in blood vessels, or they can adhere to rough surfaces and foreign material. The common drug ASA (aspirin) reduces this adhesion and can lead to an increased bleeding tendency. Thrombocytes can also initiate the coagulation process.



10-1  image


Apply Your Knowledge


Predict three possible problems that could arise in the production of blood and blood cells and explain the cause of each.



Blood Clotting


Hemostasis consists of three steps.



Clot formation (coagulation) requires a sequence or cascade of events as summarized:




The circulating clotting factors are produced primarily in the liver. Their numbers relate to the order of their discovery, not to the step in the clotting process. Vitamin K, a fat-soluble vitamin, is required for the synthesis of most clotting factors. Calcium ions are essential for many steps in the clotting process.


Other measures can be used by a person to facilitate this clotting process. For example, applying pressure and cold (a vasoconstrictor) to the site reduces blood flow in the area, or thrombin solution can be applied directly to speed up clotting.


Fibrinolysis

A delicate balance is always necessary between the tendency to clot to prevent blood loss and the tendency to form clots unnecessarily and cause infarctions. Some individuals tend to form clots very readily; others are predisposed to excessive bleeding. To prevent inappropriate thrombus formation, coagulation inhibitors such as antithrombin III circulate in the blood. Through thrombin, a prostaglandin is released to prevent platelets sticking to nearby undamaged tissue. Heparin, an anticoagulant, is released from basophils or mast cells in the tissues and exerts its major action by blocking thrombin. Heparin, as a drug, may be administered intravenously to patients at risk for thrombus formation. It does not dissolve clots, but will prevent further growth of the thrombus.


Also, there is a natural fibrinolytic process that can break down newly formed clots. Inactive plasminogen circulates in the blood. Following injury, it can be converted by tissue plasminogen activator (tPA) and streptokinase through a sequence of reactions, into plasmin. The product, plasmin, then breaks down fibrin and fibrinogen. This fibrinolysis is a localized event only, because plasmin is quickly inactivated by plasmin inhibitor. These numerous checks and balances are essential in the regulation of defense mechanisms. Application of this mechanism with “clot-buster” drugs such as streptokinase (Streptase) is proving very successful in minimizing the tissue damage resulting from blood clots causing strokes (cardiovascular accidents, CVAs) and heart attacks (myocardial infarctions, MIs). However, constant monitoring of blood-clotting times and careful administration technique are essential to prevent excessive bleeding or hematoma formation. New protocols for anticoagulant medications are under development in the United States to ensure greater safety for patients.



10-2  image


Apply Your Knowledge


Predict three ways that normal blood clotting could be impaired. Predict three ways that inappropriate blood clotting could be promoted.


Antigenic Blood Types


An individual’s blood type (e.g., ABO and Rh groups) is determined by the presence of specific antigens on the cell membranes of that person’s erythrocytes. ABO groups are an inherited characteristic that depends on the presence of type A or B antigens or agglutinogens (Table 10-1). Shortly after birth, antibodies that can react with different antigens on another person’s RBCs form in the blood of the newborn infant. Such an antigen–antibody reaction would occur with, for example, an incompatible blood transfusion, resulting in agglutination (clumping) and hemolysis of the recipient’s RBCs (Fig. 10-11).




Blood types of both donor and recipient are carefully checked before transfusion. Persons with type O blood lack A and B antigens and therefore are considered universal donors. Persons with type AB blood are universal recipients. Signs of a transfusion reaction include a feeling of warmth in the involved vein, flushed face, headache, fever and chills, pain in the chest and abdomen, decreased blood pressure, and rapid pulse.


Another inherited factor in blood is the Rh factor, which may cause blood incompatibility if the mother is Rh-negative and the fetus is Rh positive (see Fig. 22-2). Rh blood incompatibility between maternal and fetal blood is reviewed in Chapter 22.


Plasma or colloidal volume-expanding solutions can be administered without risk of a reaction because they are free of antigens and antibodies.


Diagnostic Tests


The basic diagnostic test for blood is the complete blood count (CBC), which includes total RBCs, WBCs, platelet counts, and morphology (size and shape), a differential count for WBCs, hemoglobin, and hematocrit values (see normal values inside the front cover of this book). These tests are useful screening tools. For example, leukocytosis, an increase in WBCs in the circulation, is often associated with inflammation or infection. Leukopenia, a decrease in leukocytes, occurs with some viral infections as well as with radiation and chemotherapy. An increase in eosinophils is common with allergic responses. The characteristics of the individual cells observed in a blood smear, including size and shape, uniformity, maturity, and amount of hemoglobin, are very important. Different types of anemia are distinguished by the characteristic size and shape of the cell, and presence of a nucleus in the RBC. More specialized tests are available. A summary of the most common diagnostic tests is provided in Ready Reference 5.


The hematocrit shows the percentage of blood volume composed of RBCs and indicates fluid and cell content. It may be an indicator of anemia, a low RBC count. Hemoglobin is measured, and the amount of hemoglobin per cell is shown by the mean corpuscular volume (MCV). MCV indicates the oxygen-carrying capacity of the blood.


Bone marrow function can be assessed by the reticulocyte (immature non-nucleated RBC) count, plus a bone marrow aspiration and biopsy.


Chemical analysis of the blood can determine the serum levels of such components as iron, vitamin B12 and folic acid, cholesterol, urea, glucose, and bilirubin. The results can indicate metabolic disorders and disorders within various other body systems.


Blood-clotting disorders can be differentiated by tests such as bleeding time (measures platelet function—the time to plug a small puncture wound); prothrombin time or INR International Normalized Ratio (measures the extrinsic pathway); and partial thromboplastin time (PTT—intrinsic pathway), which measure the function of various factors in the coagulation process. They are also used to monitor anticoagulant therapy. The reference values for these tests are best established for individual patients based on their health history.


Blood Therapies



• Whole blood, packed red blood cells, or packed platelets may be administered when severe anemia or thrombocytopenia develops.


• Plasma or colloidal volume-expanding solutions can be administered without risk of a reaction because they are free of antigens and antibodies.


• Artificial blood products are available, but none can perform all the complex functions of normal whole blood. They are compatible with all blood types. Hemolink is made from human hemoglobin, whereas Hemopure is made from cow hemoglobin. Oxygent is a synthetic, genetically engineered blood substitute. Other agents, such as MP4, which is undergoing clinical trials, is combined with blood to improve the oxygen transfer from RBCs to tissues. Polyethylene glycol (PEG) is also being tested by various companies to bind and stabilize hemoglobin molecules, thus decreasing the problem of the disassociation of hemoglobin that occurs in storage. Although promising, none of these artificial blood products have yet received approval from the United States Food and Drug Administration (USFDA).


• Epoetin alfa (Procrit, Eprex) is a form of erythropoietin produced through the use of recombinant DNA technology. It may be administered by injection to stimulate production of red blood cells before certain surgical procedures (e.g., hip replacement) and for patients with anemia related to cancer or chronic renal failure. This reduces the risks of infection or immune reaction associated with multiple blood transfusions.


• Bone marrow or stem cell transplants are used to treat some cancers, severe immune deficiency, or severe blood cell diseases. For success, a close match in tissue or human leukocyte antigen (HLA) type is required. The marrow stem cells are extracted from the donor’s pelvic bone, filtered, and infused into the recipient’s vein. Normal cells should appear in several weeks. In cases of malignant disease, pretreatment with chemotherapy or radiation is required to destroy tumor cells before the transplant.


• For patients suffering from a lack of blood clotting capability, there are drugs available to aid in the clotting process. Nplate is a drug that has been recently approved by the FDA that directly stimulates platelet production by the bone marrow. NovoSeven is a drug developed primarily to treat hemophiliacs, but it has been adapted for use in treating combat trauma. Although these drugs are in use today, problems with unintentional clots that may form during their use continues to be a dangerous problem that must be considered.

Stay updated, free articles. Join our Telegram channel

Nov 27, 2016 | Posted by in PATHOLOGY & LABORATORY MEDICINE | Comments Off on Blood and Circulatory System Disorders

Full access? Get Clinical Tree

Get Clinical Tree app for offline access